US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 5.520
  • -0.240-4.17%
Close Feb 28 16:00 ET
  • 5.351
  • -0.170-3.07%
Post 20:01 ET
377.44MMarket Cap-0.96P/E (TTM)

About Phathom Pharmaceuticals Company

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Company Profile

SymbolPHAT
Company NamePhathom Pharmaceuticals
Listing DateOct 25, 2019
Issue Price19.00
Founded2018
CEOMs. Terrie Curran
MarketNASDAQ
Employees452
Fiscal Year Ends12-31
Address100 Campus Drive,Suite 102
CityFlorham Park
ProvinceNew Jersey
CountryUnited States of America
Zip Code07932
Phone1-877-742-8466

Company Executives

  • Name
  • Position
  • Salary
  • Terrie Curran
  • President, Chief Executive Officer and Director
  • 3.41M
  • Azmi Nabulsi, M.D.
  • Chief Operating Officer
  • 2.04M
  • Molly Henderson
  • Chief Financial and Business Officer and Principal Accounting Officer
  • 1.87M
  • Michael F. Cola
  • Chairman of the Board
  • 331.34K
  • Dr. Asit Parikh, M.D.,PhD
  • Independent Director
  • 279.67K
  • Heidi Kunz
  • Independent Director
  • 287.17K
  • David A. Socks
  • Independent Director
  • 266.34K
  • Dr. James N. Topper, M.D.,PhD
  • Independent Director
  • 267.14K
  • Mark Stenhouse
  • Independent Director
  • 283.84K
  • Frank L. Karbe
  • Independent Director
  • 283.84K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More